Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
The momentum for targeted therapies has downstream implications for clinical laboratories
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
The skin-based test can be used on children as young as two days old
AMP Annual Meeting attendees showed strong interest in the blood test
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year
Current assays often miss diagnoses in the early stages of the disease, delaying treatment
The initiative is in conjunction with The Gift of Life registry and Doublemint Gum